METHOD FOR DETERMINING THE AGE OF RED BLOOD CELLS

Glycated Hb was measured in reticulocytes (RNA-positive cells) and was correlated to a decrease in RNA fluorescence intensity in a Log-linear dependent manner, with no statistically significant differences in slope or in the ordinate of the origin between individuals. The loss of RNA fluorescence intensity in reticulocytes observed by flow cytometry is directly related to the time they spend in circulation and consequently to their lifespan. By setting the 10 time that reticulocytes spend to mature in the blood circulation and because the relation between the decrease in log RNA fluorescence intensity and the increase in log HbA1c fluorescence intensity is linear, the inventors are able to calculate the increase in HbA1c fluorescence intensity depending on the time and thus to determine the mean half-life of a RBC population. This new tool is noninvasive and requires only one single time point measurement. 15 The present invention relates to a method for in vitro determination of the age of red blood cells of a set of red blood cells by using intracellular glycated hemoglobin measurement by flow cytometry and by using a standard curve generated from glycated hemoglobin measurement in reticulocyes.

Keywords: Glycated hemoglobin, diagnosis, Hemolysis, hemolytic anemia, red blood cell-related disorder, sickle-cell disease, beta-thalassemia, immunoassay, flow cytometry, reticulocyte
Patent Application number: European Procedure (Patents) (EPA) - 04 Avr. 2024 - 24 305 534.0
International Procedure (PCT) - 03 avril 2025 - PCT/EP2025/059115
Inventors:
HEBERT Nicolas; DJOUDER Nassima

Reference:

BIO24140-D1

Business Developper
contact
Inserm Transfert
Business Developer
Patent filling date: 2024-04-04

You might also be interested in